Trade Puma Biotechnology, Inc. - PBYI stock price

8.1972
+0.01%
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States. Its drug candidates include PB272 neratinib (oral) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 neratinib (intravenous). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
White Paper Declaration

PBYI price history

Date Close Change Chg% Open Min. Max.
2022-09-30 8.0328 0.0405 0.51 7.9923 7.9923 8.1417
2022-09-30 8.0229 -0.0290 -0.36 8.0519 7.9436 8.1814
2022-09-30 8.0625 -0.1682 -2.04 8.2307 7.9731 8.4089
2022-09-30 8.3498 0.2783 3.45 8.0715 7.9428 8.4586
2022-09-30 8.1319 0.1301 1.63 8.0018 7.4874 8.4686
2022-09-30 9.6473 -0.7615 -7.32 10.4088 9.6271 10.5579
2022-09-30 10.6279 0.3379 3.28 10.29 10.1913 10.7567
2022-09-30 10.1326 0.1394 1.39 9.9932 9.9542 10.2514
2022-09-30 10.1029 -0.3169 -3.04 10.4198 9.984 10.4298
2022-09-30 10.3506 0.0408 0.40 10.3098 10.2514 10.5188
2022-09-30 10.4001 -0.2170 -2.04 10.6171 10.39 10.6972
2022-09-30 10.5091 0.0215 0.21 10.4876 10.3702 10.8061
2022-09-30 10.7864 -0.0092 -0.09 10.7956 10.6669 10.9151
2022-09-30 10.7765 -0.1680 -1.54 10.9445 10.6179 11.1628

Mobile app

Full trading account functionality: order execution and cancellation, stop-loss and take-profit setup, transaction history, deposits and withdrawals

Dzengi Exchange
Trade BTC & tokenized stocks